submit to the journals

-Ocular Surface Disease Journal Articles, Videos And Insights

-Ocular Surface Disease:FEATURED Articles

flipper_slider

-Ocular Surface Disease: Latest Articles

-Ocular Surface Disease: INSIGHTS

The touchOPHTHALMOLOGY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of ophthalmology:

ISOPT 2018 HOT TOPIC SESSION REVIEW: DRY EYE DISEASE
Current Understanding in the use of Biomarkers in the Management of Dry Eye Disease Presenters: James V Aquavella, US; Penny A Asbell, US; Rolando Toyos, USA; David Goldblum, US; Joseph Tauber, US; Pedram Hamrah, US; Linda Rose, US

-Ocular Surface Disease:FEATURED VIDEOS

Editor's choice

We met up with Editorial Board member Bennie Jeng, who updated us on the exciting recent developments in dry eye disease and several new therapies are in development in the US. Dr Jeng talked about his experience with scleral contact lenses, which have proved particularly useful for very severe dry eye patients with GVHD and Stevens-Johnson disease in his clinic. There is still unmet need for patients with chronic severe dry eye disease patients, including access to scleral contact lenses and also recognising and understanding neuropathic pain. A better understanding of the mechanisms behind dry eye disease will help to develop new treatments. Questions: 1. What have been the most significant recent developments in the area of dry eye disease? (0:29) 2. Discuss the current unmet needs and/or the challenges you face when treating patients with dry eye disease. (1:53) 3. What developments are you most excited about in the area of dry eye disease over the next few years? (3:10) 4. Which presentations/data have interested you the most at this year’s WOC? (3:58)
Rolando and Melissa Toyos talk about their current research into intense pulse light (IPL) therapy for dry eye disease. IPL therapy is a light treatment applied to the skin to stimulate the meibomian glands to produce a better tear. The current study looks at the efficacy of IPL versus meibomian gland expression, and the results will be available in around 6 months. Another area of research is the platelet rich plasma (PRP) eye drops in the treatment of a number of conditions including oculoplastic procedures. Keywords: ISOPT 2018, Meibomian glands, dry eye disease, IPL, intense pulse light therapy, clinical trial, oculoplastics. PRP, platelet rich plasma For more information about ISOPT Clinical please visit: www.isoptclinical.com

-Ocular Surface Disease:Latest Videos

Video List based on Category on Node Page

Latest Videos

We met up with Editorial Board member Bennie Jeng, who updated us on the exciting recent developments in dry eye disease and several new therapies are in development in the US. Dr Jeng talked about his experience with scleral contact lenses, which have proved particularly useful for very severe...
Rolando and Melissa Toyos talk about their current research into intense pulse light (IPL) therapy for dry eye disease. IPL therapy is a light treatment applied to the skin to stimulate the meibomian glands to produce a better tear. The current study looks at the efficacy of IPL versus meibomian...
Maurizio Rolando discusses the key take home messages from his presentation on “The Changing Landscape of Dry Eye Disease in Europe” at SOE 2017. The filming of this video was supported by an independent educational grant from Shire Pharmaceuticals.
Michael Stern discusses the key take home messages from his presentation on Immunopathogenesis of Dry Eye Disease and Its Clinical Relevance at SOE 2017. The filming of this video was supported by an independent educational grant from Shire Pharmaceuticals.
Margarita Calonge discusses the key take home messages from her presentation on Challenges in the Management of Dry Eye Disease at SOE 2017. The filming of this video was supported by an independent educational grant from Shire Pharmaceuticals
Dr Haughom discusses the latest developments in dry eye disease and highlights the key presentations from this year’s meeting.

LATEST TWEETS

Conference Highlights